A panelist highlights that at ASCO 2025, a landmark phase 3 trial showed a new treatment significantly reduced moderate-to-severe hot flashes in patients with breast cancer receiving endocrine therapy, with rapid and sustained symptom relief and high patient continuation rates over 2 years.
A panelist explains that although hormone replacement therapy is contraindicated in patients with breast cancer due to recurrence risks, new nonhormonal treatments targeting neurokinin receptors in the brain offer promising relief for vasomotor symptoms without interfering with endocrine therapy.
Health care providers are using short-form videos on TikTok to educate young women about Pap tests, breaking down barriers with engaging, accessible content.
New research shows up to 17% of reproductive-aged women visit crisis pregnancy centers, raising alarms over misinformation and lack of regulation.
A panelist notes that although chemotherapy’s adverse effects are intense but short-lived, endocrine therapy for hormone receptor–positive breast cancer involves persistent symptoms over several years, making symptom management essential for patient adherence and quality of life.
A panelist discusses how endocrine therapy remains the cornerstone of treatment for hormone receptor–positive, HER2-negative breast cancer, emphasizing its role in reducing relapse risk and mortality while highlighting the importance of tolerability and individualized care across the subtype’s heterogeneous presentations.
Learn how to identify early symptoms of preeclampsia and improve outcomes with timely screening, diagnosis, and prevention strategies from Eran Bornstein, MD.
Comprehensive first trimester screening can identify over 90% of early preeclampsia cases, allowing timely intervention with low-dose aspirin to significantly reduce risks for both mother and baby.
Learn how postpartum psychosis impacts maternal health, the role of family history, and key steps to identify and prevent this serious but treatable condition.
A universal aspirin initiative at a Bronx hospital increased prescribing rates from 30% to 99% and is now being evaluated for its impact on preeclampsia.
Considerations for reducing blood loss, morbidity, and surgical complexity in patients with large fibroids.
Integrating oral health checks into standard clinical assessments can improve overall patient outcomes and reduce the risk of systemic diseases linked to gum and dental issues.
New research reveals a strong connection between poor oral health, oral microbiota, and heightened pain sensitivity in women with central sensitisation disorders.
Women with dense breast tissue face higher cancer risks and diagnostic challenges, but new research reveals contrast imaging may significantly improve early detection.
Watch some highlights from our discussions with experts presenting at the 2025 ACOG meeting.
A structured surgical approach, imaging tools, and careful platform choice support optimal endometriosis management, according to Trina Mansour, MD, at the 2025 ACOG ACSM.
Tia Welsh, MD, MPH, FACOG, shares new evidence showing that single-use negative pressure wound therapy at -80 mmHg lowers cesarean-section infection rates and healthcare costs more effectively than traditional -125 mmHg therapy.
Amy Valent, DO, MCR, discusses how continuous glucose monitors and smart insulin delivery tools are reshaping individualized care for pregnant patients with diabetes.
Lisa Bayer, MD, MPH, details her presentation at the 2025 ACOG ACSM pain management during IUD placement.
Megan Wasson, DO, discusses surgical precision, imaging, and mentorship to improve endometriosis care at the 2025 ACOG Annual Meeting.
Megan Cohen, MD, MPH, outlines major changes to the CDC’s 2024 contraceptive recommendations, including updated safety classifications, inclusive language, and new guidance for transgender and medically complex patients.
Megan Wasson, DO, and Ceylan Colak, MD, highlight how imaging and multidisciplinary care improve endometriosis diagnosis, treatment, and patient outcomes at the 2025 ACOG ACSM.
In this interview at the 2025 ACOG ACSM, Johanna Finkle, MD, urged clinicians to tailor weight loss care based on BMI, contraception use, and medication risks using patient-centered counseling.
Erin Keyser, MD, FACOG, breaks down the latest approaches to hormone therapy for menopause, emphasizing personalized care and shared decision-making.
Tia Welsh, MD, MPH, FACOG, highlights how primary HPV screening, self-collection, and extended genotyping are transforming cervical cancer detection and improving access for underserved populations.
Elizabeth Evans, MD, and Deslyn Hobson, MD, highlight how non-estrogen therapies such as ospemifene can effectively manage symptoms
Despite widespread awareness of guidelines, many health care providers fall short in consistently screening and referring postpartum women for depression, putting maternal mental health at risk.
Jill Liss, MD, shares details on her presentation on the physiology of menopause care and how clinicians can use evidence to improve patient care at the 2025 ACOG ACSM.
Elizabeth Mollard, PhD, WHNP, CNM, shares her research, presented at the 2025 ACOG ACSM, on Medicaid postpartum depression (PPD) screening and coverage policies on PPD diagnosis.
Victoria Wang, MD, discusses updated ASCCP recommendations for post-treatment monitoring of high-grade dysplasia and the importance of identifying high-risk patients early.
